Skip to main content

Table 1 The clinical characteristics between survivors and non-survivors

From: The associations between fasting blood glucose levels and mortality of SFTS in patients

  Survivors N = 61 Non-survivors N = 16 P values
Age, years, median (IQR) 63 (55–69) 66 (61–72) 0.26
Gender (Male/Female) 34/27 8/8 0.682
Time from onset to admission (days) 5 (4–7) 5 (5–7) 0.969
Duration of hospital admission (days) 12 (9–16) 4.5 (1.2–7.7) < 0.001
Treatment, n (%)
 Oxygen therapy 30 (49.1) 16 (100) < 0.001
 Ribavirin 59 (96.7) 16 (100) 0.463
 Antibacterial treatment 34 (55.7) 11 (68.7) 0.347
 Antifungal treatment 14 (22.9) 1 (6.2) 0.133
 Glucocorticoids 26 (42.6) 10 (62.5) 0.156
 Intravenous immunoglobulin 52 (85.2) 16 (100) 0.102
 Use of blood product 29 (47.5) 9 (56.2) < 0.001
 Fasting blood glucose (mmol/L) 6.9 (5.3–9.5) 10.1 (12.9) 0.015
 Leukocytes (×109/L) 2.32 (1.6–3.9) 2.3 (1.4–3.5) 0.551
 Neutrophils (×109/L) 1.3 (0.8–2.3) 1.2 (0.8–2.3) 0.90
 Platelet (×109/L) 46 (34–68) 40 (25–52) 0.189
 Procalcitonin (ng/ml) 0.11 (0.05–0.22) 0.54 (0.15–0.89) 0.001
 C-reactive protein (mg/L) 3.1 (0.8–9.2) 4.7 (2.0–12.8) 0.177
 Aspartate aminotransferase (U/L) 120 (89.5–232) 457 (128–706) 0.005
 Alanine aminotransferase (U/L) 75 (43.5–92) 97 (59–178) 0.034
 Creatinine (μmol/L) 67.5 (58–88.1) 94.2 (76–166) 0.001
 lactate dehydrogenase (U/L) 827 (562–1556) 1720 (1008–5761) 0.002
 Creatine kinase (U/L) 316 (116–731) 580 (185–3563) 0.096
 PT, secs. 13.5 (12.8–13.9) 13.6 (12.8–15.2) 0.397
 APTT, secs. 50.4 (42.8–54.8) 67.7 (54.4–85.5) < 0.001
 D-Dimer (μg/mL) 1.87 (1.27–3.61) 6.7 (2.8–15.7) < 0.001
 Fibrin degradation product (μg/mL) 5.98 (3.77–12.3) 19.7 (8.9–63.2) 0.001
 Serum amyalse (U/L) 99 (30–681) 99.5 (55–392) 0.56
 Serum lipase (U/L) 559 (27–2000) 581 (105–1576) 0.95
 Interleukin-1β (pg/ml) 8.1 (5.0–13.5) 22.7 (10.9–36.0) < 0.001
 Interleukin-2R (U/ml) 1106 (841–1381) 1714 (1267–2803) 0.001
 Interleukin-6 (pg/ml) 10.8 (5.0–16.3) 68.7 (20.4–140.0) < 0.001
 Interleukin-8 (pg/ml) 20.5 (14.9–32.4) 73.5 (34.4–232.5) 0.001
 Interleukin-10 (pg/ml) 36 (10.4–63.6) 117 (53.8–275.5) < 0.001
 Tumor necrosis factor-α (pg/ml) 18.4 (14.8–24.0) 47.4 (27.3–116.3) < 0.001